Cytomegalovirus Retinitis
- 1 May 2006
- journal article
- review article
- Published by Wolters Kluwer Health in International Ophthalmology Clinics
- Vol. 46 (2), 91-110
- https://doi.org/10.1097/00004397-200604620-00010
Abstract
No abstract availableThis publication has 113 references indexed in Scilit:
- Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progressionOphthalmology, 2004
- A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitisAntiviral Research, 2004
- Perforin knockout mice, but not mice with MAIDS, show protection against experimental cytomegalovirus retinitis after adoptive transfer of immune cells with a functional perforin cytotoxic pathwayArchiv für die gesamte Virusforschung, 2004
- Pathogenesis of human cytomegalovirus infection and cellular targetsHuman Immunology, 2004
- A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus RetinitisNew England Journal of Medicine, 2002
- Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapyAmerican Journal of Ophthalmology, 2002
- Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNABone Marrow Transplantation, 2001
- Evaluation by polymerase chain reaction of cytomegalovirus reactivation in intensive care patients under mechanical ventilationIntensive Care Medicine, 1996
- Cytomegalovirus Seroprevalence in Women Bearing Children in Jefferson County, KentuckyThe American Journal of the Medical Sciences, 1993
- Mortality in Patients with the Acquired Immunodeficiency Syndrome Treated with either Foscarnet or Ganciclovir for Cytomegalovirus RetinitisNew England Journal of Medicine, 1992